MedPath
NMPA Approval

Levosalbutamol Hydrochloride Nebuliser Solution

国药准字HJ20220009

February 18, 2022

Drug Information

盐酸左沙丁胺醇雾化吸入溶液

吸入制剂(吸入溶液)

3ml:1.25mg(按C13H21NO3计)

化学药品

February 18, 2022

February 17, 2027

Company Information

Applicant Company

1 Technology Cir, Columbia, SC 29203 United States of America

Manufacturing Company

1 Technology Cir, Columbia, SC 29203 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左沙丁胺醇雾化吸入溶液 - NMPA 批准文号 | MedPath